I DON'T MAKE ANY MONEY OFF THIS SITE

If this helps you and you want to make sure it continues, please donate.

Donate
Back to results

Breckenridge recalls Duloxetine delayed-release capsules due to carcinogen risk

via Top Class Actions Published: Jun 30, 2026

Summary

Breckenridge Pharmaceutical is recalling nearly 370,000 bottles of Duloxetine delayed-release capsules due to potential contamination with N-nitroso-duloxetine, a substance classified as a probable carcinogen.... Read More The post Breckenridge recalls Duloxetine delayed-release capsules due to carcinogen risk appeared first on Top Class Actions.

Read full article →